Report Detail
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Professional Survey Report 2019
- RnM3742142 |
- 07 July, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is segmented into
Immune DTaP Vaccine
Therapy DTaP Vaccine
Segment by Application, the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is segmented into
Adult
Pediatric
Regional and Country-level Analysis
The Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share Analysis
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine business, the date to enter into the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
1 Study Coverage
- 1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type
- 1.4.2 Immune DTaP Vaccine
- 1.4.3 Therapy DTaP Vaccine
- 1.5 Market by Application
- 1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Application
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2015-2026
- 2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2015-2026
- 2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Competitor Landscape by Players
- 3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
- 3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers
- 3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2019
- 3.2.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
- 3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2015-2020)
- 4.1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2015-2020)
- 5.1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Application (2015-2020)
- 5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Country
- 6.1.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country
- 6.1.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Type
- 6.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Country
- 7.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country
- 7.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Type
- 7.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Region
- 8.1.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region
- 8.1.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Country
- 9.1.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country
- 9.1.2 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Country
- 10.1.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country
- 10.1.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Sanofi Pasteur
- 11.1.1 Sanofi Pasteur Corporation Information
- 11.1.2 Sanofi Pasteur Description and Business Overview
- 11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.1.5 Sanofi Pasteur Related Developments
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Corporation Information
- 11.2.2 GlaxoSmithKline Description and Business Overview
- 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.2.5 GlaxoSmithKline Related Developments
- 11.3 Protein Sciences Corporation
- 11.3.1 Protein Sciences Corporation Corporation Information
- 11.3.2 Protein Sciences Corporation Description and Business Overview
- 11.3.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.3.5 Protein Sciences Corporation Related Developments
- 11.4 Novartis AG
- 11.4.1 Novartis AG Corporation Information
- 11.4.2 Novartis AG Description and Business Overview
- 11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.4.5 Novartis AG Related Developments
- 11.5 Seqirus
- 11.5.1 Seqirus Corporation Information
- 11.5.2 Seqirus Description and Business Overview
- 11.5.3 Seqirus Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.5.5 Seqirus Related Developments
- 11.6 Merck Sharp & Dohme Corp
- 11.6.1 Merck Sharp & Dohme Corp Corporation Information
- 11.6.2 Merck Sharp & Dohme Corp Description and Business Overview
- 11.6.3 Merck Sharp & Dohme Corp Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.6.5 Merck Sharp & Dohme Corp Related Developments
- 11.7 Astellas Pharma US
- 11.7.1 Astellas Pharma US Corporation Information
- 11.7.2 Astellas Pharma US Description and Business Overview
- 11.7.3 Astellas Pharma US Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.7.5 Astellas Pharma US Related Developments
- 11.8 Pfizer Inc
- 11.8.1 Pfizer Inc Corporation Information
- 11.8.2 Pfizer Inc Description and Business Overview
- 11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.8.5 Pfizer Inc Related Developments
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Corporation Information
- 11.9.2 Johnson & Johnson Description and Business Overview
- 11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.9.5 Johnson & Johnson Related Developments
- 11.10 Lanzhou Institute of Biological Products Co., Ltd
- 11.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
- 11.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
- 11.10.3 Lanzhou Institute of Biological Products Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.10.5 Lanzhou Institute of Biological Products Co., Ltd Related Developments
- 11.1 Sanofi Pasteur
- 11.1.1 Sanofi Pasteur Corporation Information
- 11.1.2 Sanofi Pasteur Description and Business Overview
- 11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.1.5 Sanofi Pasteur Related Developments
- 11.12 Emergent BioSolutions Inc
- 11.12.1 Emergent BioSolutions Inc Corporation Information
- 11.12.2 Emergent BioSolutions Inc Description and Business Overview
- 11.12.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Emergent BioSolutions Inc Products Offered
- 11.12.5 Emergent BioSolutions Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine. Industry analysis & Market Report on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is a syndicated market report, published as Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
